1 completed, 1 withdrawn. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
Follow Hemanext: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Investigation to Evaluate the Hemanext® Red Blood Cell Processing System for Extended Storage of Leukoreduced Red Blood Cells Hemanext One - Whole Blood Donations and Leukoreduction | Phase 2 | Withdrawn | Hemanext | 2020-07-01 | 2020-08-03 | |
| Clinical Investigation to Evaluate the Hemanext® Oxygen Reduction System - Pivotal Trial Hemanext Red Blood Cell Processing System - Whole Blood Donation and Leukoreduction | Phase 2 | Completed | Hemanext | 100 | 2017-11-27 | 2020-06-23 |
United States (2)
Faye West, MD (1) · Jose A Cancelas Perez, MD, PhD (1) · Jose Cancelas, MD, PhD (1) · Matthew Karafin, MD (1) · Philip Howard, MD (1)